Year in Review: Breast Cancer

Practice-changing therapy for HER2-low breast cancer, potential for some women to skip surgery

Related Keywords

United States ,Paris ,France General ,France ,Hebron ,Israel General ,Israel ,Stockholm ,Sweden ,Dana Farber Cancer Institute ,Massachusetts ,Philadelphia ,Pennsylvania ,Boston ,University Of Pennsylvania ,Houston ,Texas ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Swedish ,American ,Angela Demichele ,Heathera Parsons ,Jane Lowe Meisel ,Annelie Johansson ,Henry Kuerer ,Nancy Davidson ,Meritxell Bellet Ezquerra ,Karolinska Institute ,American Society Of Clinical Oncology ,Md Anderson Cancer Center ,Harvard Medical School ,Fred Hutchinson Cancer Center ,University Of Washington ,Hebron Institute Of Oncology ,University Of California San Francisco ,European Society For Medical Oncology ,Shanu Modi ,American Society ,Clinical Oncology ,Winship Cancer Center ,Emory University ,Cancer Center ,California San Francisco ,European Society ,Medical Oncology ,Hebron Institute ,